Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Apple Tree Partners (ATP) is a venture capital firm founded in 1999 and based in the United States. The firm specializes in life sciences, particularly in the development of biotechnology companies. ATP creates and invests in companies at various stages, from pre-IP ideas to asset spinouts, providing flexible capital and strategic resources to build sustainable, research-driven enterprises.
As of now, ATP manages a portfolio of 30 companies, focusing exclusively on the life sciences industry. The firm has established a reputation for its deep expertise in biotechnology, which allows it to support companies from inception through IPO. ATP's notable milestones include its consistent investment in innovative biotech firms and its role in facilitating spinouts from existing company pipelines.
ATP invests in life sciences companies, supporting them from seed stage through IPO and beyond. Their investment strategy includes working closely with scientists on pre-IP ideas and facilitating spinouts from existing company pipelines. This approach allows ATP to identify and nurture innovative concepts that have the potential to transform the healthcare landscape.
The firm focuses on biotech and healthcare sectors, providing capital that ranges from seed funding to later-stage investments. ATP seeks to partner with founders who demonstrate a strong commitment to research and development, as well as a clear vision for their companies. Their deal structure preferences include flexible capital solutions that align with the unique needs of each startup.
ATP's portfolio includes a diverse range of biotechnology companies, showcasing their commitment to innovation in life sciences. Notable portfolio companies include:
This extensive portfolio reflects ATP's focus on supporting innovative companies that are poised to make significant contributions to the life sciences sector.
Seth L. Harrison, MD - Founder and Managing Partner. Dr. Harrison has extensive experience in the life sciences sector and has led numerous successful investments in biotechnology.
Marie-Therese Afif - Head of Operations. Afif oversees the operational aspects of ATP, ensuring efficient management of the firm's portfolio.
Anna Batarina, CFA - Partner. Batarina brings financial expertise and has been involved in various successful funding rounds.
Paul Eisenberg, MD - Chief Medical Officer and Venture Partner. Dr. Eisenberg provides medical insights and guidance to portfolio companies.
Daniel Finkelman - General Counsel. Finkelman handles legal matters and compliance for ATP.
Sally Jacob - Head of Communications. Jacob manages ATP's public relations and communication strategies.
Neena Kadaba, PhD - Kadaba contributes scientific expertise to ATP's investment decisions.
Spiros Liras, PhD - Liras provides insights into biotechnology trends and innovations.
Stephanie Maiocco, PhD - Maiocco supports the firm's investment strategy with her scientific background.
Mark Mitchnick, MD - Mitchnick offers medical expertise and strategic guidance to portfolio companies.
Vern Norviel - Norviel plays a key role in ATP's investment operations.
John F. Reilly, PhD - Reilly provides scientific insights and supports due diligence efforts.
Aileen Salares, CFA - Salares contributes financial analysis and investment strategy.
Brian Vash - Vash is involved in ATP's investment processes and portfolio management.
Joseph A. Yanchik III - Yanchik supports ATP's operational and investment strategies.
Eva Zhou - Zhou contributes to ATP's research and analysis efforts.
Startups should pitch ATP via email at info@appletreepartners.com. A comprehensive pitch deck is essential, detailing the business model, market analysis, and team qualifications. Response times may vary, so founders should be prepared for potential follow-up discussions.
In recent months, ATP has continued to expand its portfolio, adding several promising biotechnology companies. Notable investments include Aethon Therapeutics and Chinook Therapeutics, both of which are making strides in their respective fields.
ATP remains active in the life sciences sector, focusing on innovative solutions that address critical healthcare challenges. The firm is also exploring new opportunities for collaboration with other venture capital firms and industry leaders.
What are ATP's investment criteria?
ATP focuses on life sciences companies, particularly in biotech and healthcare. They invest at various stages, from seed to IPO, and prioritize partnerships with founders who have a strong commitment to research and development.
How can startups apply or pitch to ATP?
Startups can reach out to ATP via email at info@appletreepartners.com. They should include a detailed pitch deck outlining their business model, market opportunity, and team background.
What makes ATP different from other venture capital firms?
ATP's deep expertise in life sciences and their focus on supporting companies from inception through IPO set them apart. They provide flexible capital and strategic resources tailored to the unique needs of biotech startups.
What is ATP's geographic scope?
ATP primarily invests in companies based in the United States, focusing on the life sciences sector.
What is ATP's post-investment involvement like?
ATP actively engages with portfolio companies, offering operational support, strategic guidance, and access to their extensive network in the life sciences industry.
What is the typical check size for ATP's investments?
ATP invests across various stages, with check sizes varying depending on the stage of the company and its specific needs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.